Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
The recent outbreak of Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been characterized by the World Health Organization (WHO) as a controllable global pandemic. The spike (S) glycoprotein mediates binding to the angiotensin-...
Saved in:
Main Authors: | Chao Zhang (Author), Chenliang Zhou (Author), Li Shi (Author), Ge Liu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary Surfactant: possible intervention against the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
by: Elaine Díaz Casañas, et al.
Published: (2020) -
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) vaccine acceptance in employees in an integrated health system in the Midwest
by: Hayden L. Smith, et al.
Published: (2021) -
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19)
by: Su Eun Park
Published: (2020) -
Modeling the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on skin, currency, and clothing.
by: David E Harbourt, et al.
Published: (2020) -
Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi India
by: Utkarsh Srivastava, et al.
Published: (2022)